N-myristoyltransferase in the leukocytic development processes

被引:0
|
作者
Sujeet Kumar
Baljit Singh
Jonathan R. Dimmock
Rajendra K. Sharma
机构
[1] University of Saskatchewan,Department of Pathology and Laboratory Medicine, College of Medicine
[2] Saskatchewan Cancer Agency,Cancer Research Unit
[3] University of Saskatchewan,Department of Veterinary Biomedical Sciences
[4] Western College of Veterinary Medicine,Drug Design and Discovery Research Group
[5] College of Pharmacy and Nutrition,undefined
[6] University of Saskatchewan,undefined
来源
Cell and Tissue Research | 2011年 / 345卷
关键词
N-myristoyltransferase; Lipid modification; Myristoylation; Leukocyte development;
D O I
暂无
中图分类号
学科分类号
摘要
The lipidic modification of proteins has recently been shown to be of immense importance, although many of the roles of these modifications remain as yet unidentified. One of such key modifications occurring on several proteins is the covalent addition of a 14-carbon long saturated fatty acid, a process termed myristoylation. Myristoylation can occur during both co-translational protein synthesis and posttranslationally, confers lipophilicity to protein molecules, and controls protein functions. The protein myristoylation process is catalyzed by the enzyme N-myristoyltransferase (NMT), which exists as two isoforms: NMT1 and NMT2. NMT1 is essential for growth and development, during which rapid cellular proliferation is required, in a variety of organisms. NMT1 is also reported to be elevated in many cancerous states, which also involve rapid cellular growth, albeit in an unwanted and uncontrolled manner. The delineation of myristoylation-dependent cellular functions is still in a state of infancy, and many of the roles of the myristoylated proteins remain to be established. The development of cells of the leukocytic lineage represents a phase of rapid growth and development, and we have observed that NMT1 plays a role in this process. The current review outlines the roles of NMT1 in the growth and differentiation of the cells of leukocytic origin. The described studies clearly demonstrate the roles of NMT1 in the regulation of the developmental processes of the leukocytes cells and provide a basis for further research with the aim of unraveling the roles of protein myristoylation in both cellular and physiological context.
引用
收藏
页码:203 / 211
页数:8
相关论文
共 50 条
  • [41] The structure of myristoyl-CoA:protein N-myristoyltransferase
    Bhatnagar, RS
    Fütterer, K
    Waksman, G
    Gordon, JI
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1441 (2-3): : 162 - 172
  • [42] Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
    Fenwick, Michael K.
    Reers, Alexandra R.
    Liu, Yi
    Zigweid, Rachael
    Sankaran, Banumathi
    Shin, Janis
    Hulverson, Matthew A.
    Hammerson, Bradley
    Alvaro, Elena Fernandez
    Myler, Peter J.
    Kaushansky, Alexis
    Van Voorhis, Wesley C.
    Fan, Erkang
    Staker, Bart L.
    ACS INFECTIOUS DISEASES, 2023, 9 (10): : 1821 - 1833
  • [43] Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
    Corpas-Lopez, Victoriano
    Moniz, Sonia
    Thomas, Michael
    Wall, Richard J.
    Torrie, Leah S.
    Zander-Dinse, Dorothea
    Tinti, Michele
    Brand, Stephen
    Stojanovski, Laste
    Manthri, Sujatha
    Hallyburton, Irene
    Zuccotto, Fabio
    Wyatt, Paul G.
    De Rycker, Manu
    Horn, David
    Ferguson, Michael A. J.
    Clos, Joachim
    Read, Kevin D.
    Fairlamb, Alan H.
    Gilbert, Ian H.
    Wyllie, Susan
    ACS INFECTIOUS DISEASES, 2019, 5 (01): : 111 - 122
  • [44] QSAR analysis of N-myristoyltransferase inhibitors: antifungal activity of benzofurans
    Hemantkumar S. Deokar
    Purushottamachar Puranik
    Vithal M. Kulkarni
    Medicinal Chemistry Research, 2009, 18 : 206 - 220
  • [45] EXPRESSION AND ACTIVITIES OF N-MYRISTOYLTRANSFERASE AND CALCINEURIN IN NORMAL AND INFLAMED LUNGS
    Charavaryamath, Chandrashekhar
    Lemieux, Hollie
    Suri, Sarabjeet Singh
    Selvakumar, Ponniah
    Sharma, Rajendra K.
    Singh, Baljit
    EXPERIMENTAL LUNG RESEARCH, 2009, 35 (09) : 729 - 747
  • [46] MECHANISMS OF ACTION OF NIP71 ON N-MYRISTOYLTRANSFERASE ACTIVITY
    KING, MJ
    SHARMA, RK
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1994, 141 (02) : 79 - 86
  • [47] Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs
    Rajiv S. Bhatnagar
    Klaus Fütterer
    Thalia A. Farazi
    Sergey Korolev
    Clare L. Murray
    Emily Jackson-Machelski
    George W. Gokel
    Jeffrey I. Gordon
    Gabriel Waksman
    Nature Structural Biology, 1998, 5 : 1091 - 1097
  • [48] IDENTIFICATION AND CHARACTERIZATION OF MULTIPLE FORMS OF BOVINE BRAIN N-MYRISTOYLTRANSFERASE
    GLOVER, CJ
    FELSTED, RL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (39) : 23226 - 23233
  • [49] Recombinant bovine spleen myristoyl CoA: Protein N-myristoyltransferase
    Raju, RVS
    Datla, RSS
    Kakkar, R
    Sharma, RK
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 189 (1-2) : 91 - 97
  • [50] N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
    Julie A. Frearson
    Stephen Brand
    Stuart P. McElroy
    Laura A. T. Cleghorn
    Ondrej Smid
    Laste Stojanovski
    Helen P. Price
    M. Lucia S. Guther
    Leah S. Torrie
    David A. Robinson
    Irene Hallyburton
    Chidochangu P. Mpamhanga
    James A. Brannigan
    Anthony J. Wilkinson
    Michael Hodgkinson
    Raymond Hui
    Wei Qiu
    Olawale G. Raimi
    Daan M. F. van Aalten
    Ruth Brenk
    Ian H. Gilbert
    Kevin D. Read
    Alan H. Fairlamb
    Michael A. J. Ferguson
    Deborah F. Smith
    Paul G. Wyatt
    Nature, 2010, 464 : 728 - 732